Keryx Biopharmaceuticals Inc Watch

from 425 3 pages First Amendment to Agreement and Plan of Merger

from 425 3 pages First Amendment to Agreement and Plan of Merger

from 8-K 3 pages First Amendment to Agreement and Plan of Merger

from 8-K 106 pages Agreement and Plan of Merger by and Among Akebia Therapeutics, Inc., Alpha Therapeutics Merger Sub, Inc., and Keryx Biopharmaceuticals, Inc. Dated June 28, 2018

from 425 106 pages Agreement and Plan of Merger by and Among Akebia Therapeutics, Inc., Alpha Therapeutics Merger Sub, Inc., and Keryx Biopharmaceuticals, Inc. Dated June 28, 2018

from 425 106 pages Agreement and Plan of Merger by and Among Akebia Therapeutics, Inc., Alpha Therapeutics Merger Sub, Inc., and Keryx Biopharmaceuticals, Inc. Dated June 28, 2018

from 8-K 2 pages Amendment to Asset Purchase Agreement Dated as of March 16, 2006 (The "Amendment") Among Ausam Biotechnologies, Inc., a Delaware Corporation (“Seller”), Keryx Biopharmaceuticals, Inc., a Delaware Corporation, (“Parent”), Accumin Diagnostics, Inc., a Delaware Corporation (“Purchaser”) and Assented to by Trident Growth Fund, L.P. (“Trident”), Northshore Asset Management, LLC ("Nsam") and Dr. Wayne Comper (“Comper”)

from 8-K 32 pages Asset Purchase Agreement Dated as of February 6, 2006 Among Ausam Biotechnologies, Inc., a Delaware Corporation (“Seller”), Keryx Biopharmaceuticals, Inc., a Delaware Corporation, (“Parent”), Accumin Diagnostics, Inc., a Delaware Corporation (“Purchaser”), And, Solely for Purposes of Sections 10.4 and 10.10, Trident Growth Fund, L.P. (“Trident”), Northshore Asset Management, LLC ("Nsam") and Dr. Wayne Comper (“Comper”)

from 8-K ~10 pages First Amendment to Agreement and Plan of Merger

from 8-K ~50 pages Agreement and Plan of Merger

from S-1 ~20 pages Asset Purchase Agmt November 18, 1999

from S-1 ~20 pages Asset Purchase Agmt November 11, 1999